<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information, for the period ended 
June 30, 1997, restated to reflect the combined results of Incyte 
Pharmaceuticals, Inc. and Synteni, Inc. 
</LEGEND>
<RESTATED>
<MULTIPLIER> 1,000
       
                             
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                          17,340
<SECURITIES>                                    26,597
<RECEIVABLES>                                    3,966
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                50,068
<PP&E>                                          40,610
<DEPRECIATION>                                  14,359
<TOTAL-ASSETS>                                  83,502
<CURRENT-LIABILITIES>                           32,123
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            23
<OTHER-SE>                                      50,903
<TOTAL-LIABILITY-AND-EQUITY>                    83,502
<SALES>                                              0
<TOTAL-REVENUES>                                39,423
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                32,503
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  1,886
<INCOME-TAX>                                       158
<INCOME-CONTINUING>                              1,728
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,728
<EPS-PRIMARY>                                     0.07
<EPS-DILUTED>                                     0.07